Colchicine to reduce coronavirus disease-19-related inflammation and cardiovascular complications in high-risk patients post-acute infection with SARS-COV-2—a study protocol for a randomized controlled trial

Peer Review reports

Original Submission
6 Mar 2024	Submitted	Original manuscript
21 May 2024	Reviewed	Reviewer Report - Kirsty Loudon
27 May 2024	Author responded	Author comments - Shani S Thankachen
Resubmission - Version 2
27 May 2024	Submitted	Manuscript version 2
Publishing
28 May 2024	Editorially accepted
12 Jun 2024	Article published	10.1186/s13063-024-08205-7

Back to article page